OVCA2 acts as an oncogene in pediatric AML by negatively regulating CDKN1A to drive cell cycle progression
{{output}}
Objectives: Pediatric acute myeloid leukemia (AML) is biologically distinct from adult AML and carries a poor prognosis. OVCA2, a serine hydrolase with context-dependent roles, has unknown function in AML. We aimed to investigate... ...
